WiseTech Global (ASX:WTC) The e2open Earnings Reality Check And What Comes For FY26
Cheapest Multiple in 5 Years, But the Market Wants Proof WiseTech is a company we have been covering at Stocks…
Forecasts for the Key ASX Sectors in 2026
The Australian Stock Exchange is seeing all the different sectors performing at all levels of speed. In 2026, investors ask…
7 ASX Stocks Positioned to Win as Financial Services Battle for Talent Reaches Crisis Point
Australian financial services companies are facing their most acute talent shortage in over a decade. A recent study by the…
The Magnificent Seven Tech Stocks and AI: Are they keeping pace or falling behind the competition? And are investors aware of the reality?
Magnificent Seven Tech Stocks and AI are a fascinating pair. It could give them another 1-2 decades of dominance at…
Here are 7 AI IPOs set to happen in 2026! Could these companies be the giants of tomorrow?
Let’s take a look at AI IPOs set to happen in 2026. Unfortunately, it is unlikely Australia will see too…
Nanosonics (ASX:NAN) Revenue Up 9%, But Operating Leverage Still Missing
Nanosonics Investors Want Margin Accretion, This Half Did Not Deliver It Nanosonics saw its share price fall 7% to around…
ARB Corporation (ASX:ARB) Down 15% as Margins Reset and Earnings Slide
ARB Corporation A Small Revenue Dip, A Big Profit Hit, Here’s Why ARB Corporation had a sharp 15% fall today…
Monadelphous Group (ASX:MND) A Clean Beat, Revenue Up 45%, Profit Up 52%
Monadelphous Group Earnings Quality Improves as Construction Surges Monadelphous Group had a strong re rate on its half year result,…
Best ASX Dividend Stocks in 2026: 5 Payouts That Beat Expectations
ASX Dividend Stocks 2026: The Biggest Surprises This Season This ASX reporting season is telling two very different dividend stories.…
Imdex (ASX:IMD) Hits Record Revenue but Profit Misses: Buy or Wait?
Imdex (ASX: IMD) rose 8.2% on Monday after delivering its strongest-ever first half. Revenue jumped 16% to A$246.6 million, and…
Here are 4 ASX biotechs with major milestones coming right up!
Investing in ASX biotechs is a risky business, even more than most other companies on the market. Unless you own…
An Australian Investor’s Guide to Cryptocurrency in 2026!
At Stocks Down Under, we’ve written a lot about crypto, but we have never written a broad Guide to Cryptocurrency…
If you decide to start investing in 2026, here’s how you should approach it
If you want to start investing in 2026 to say it is a turbulent environment is an understatement. An undercurrent…
Woolworths vs Coles: Which Supermarket Stock Wins This Reporting Season?
Woolworths vs Coles: Margin pressure meets reporting season Woolworths Group (ASX: WOW) and Coles Group (ASX: COL) are both reporting…
Is Fisher & Paykel Healthcare (ASX:FPH) a Buy After Upgrading Guidance? The Tariff Risk Investors Are Ignoring
Fisher & Paykel Healthcare (ASX: FPH) lifted its FY26 guidance on Monday, now expecting around NZ$2.30 billion in revenue and…